نتایج جستجو برای: tp53

تعداد نتایج: 8206  

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2005
J Andersson L Larsson S Klaar L Holmberg J Nilsson M Inganäs G Carlsson J Ohd C-M Rudenstam B Gustavsson J Bergh

BACKGROUND TP53 has been described as a prognostic factor in many malignancies, including breast cancer. Whether it also might be a predictive factor with reference to chemo- and endocrine therapy is more controversial. PATIENTS AND METHODS We investigated relapse-free (RFS), breast cancer-corrected (BCCS) and overall survival (OS) related to TP53 status in node-positive breast cancer patient...

Journal: :Journal of medical genetics 1995
C MacGeoch G Turner L G Bobrow D M Barnes D T Bishop N K Spurr

We have screened two families for constitutional TP53 mutations, one family with Li-Fraumeni syndrome and the other with features of this syndrome. We report a germline mutation in exon 7 of the TP53 gene in the family with "Li-Fraumeni-like" syndrome. The mutation occurred at codon 245 and causes a Gly-Ser amino acid change. It was inherited by both affected and unaffected subjects. Malignant ...

Journal: :Neuro-oncology 2022

Abstract Glioma accounts for 80% of all malignant brain tumours and is the most common adult primary tumour. Age an important factor affecting development cancer, as somatic mutations accumulate with age. Here, we aimed to analyse significance age-dependent non-silent in glioma prognosis. Histological tumour grade depends on age at diagnosis patients IDH1, TP53, ATRX, EGFR mutations. wild-type ...

Journal: :American journal of medical genetics. Part A 2008
Faith Pangilinan Kerry Geiler Jessica Dolle James Troendle Deborah A Swanson Anne M Molloy Marie Sutton Mary Conley Peadar N Kirke John M Scott James L Mills Lawrence C Brody

Genetic and environmental factors contribute to the etiology of neural tube defects (NTDs). While periconceptional folic acid supplementation is known to significantly reduce the risk of NTDs, folate metabolic pathway related factors do not account for all NTDs. Evidence from mouse models indicates that the tumor protein p53 (TP53) is involved in implantation and normal neural tube development....

Journal: :Annals of hepatology 2005
Mauricio Moreno Fernando Pimentel Adi F Gazdar Ignacio I Wistuba Juan F Miquel

BACKGROUND Gallbladder carcinoma (GBC) is a frequent neoplasm in Hispanic and native American populations. GBC is preceded by gallstones, chronic cholecystitis and dysplastic changes of the gallbladder epithelium. The knowledge of the molecular events involved in its pathogenesis is scarce. AIMS We investigated the role of TP53 inactivation in the sequential pathogenesis of GBC. METHODS Inv...

2010
Ahmed Ashour Ahmed Dariush Etemadmoghadam Jillian Temple Andy G Lynch Mohamed Riad Raghwa Sharma Colin Stewart Sian Fereday Carlos Caldas Anna deFazio David Bowtell James D Brenton

Numerous studies have tested the association between TP53 mutations in ovarian cancer and prognosis but these have been consistently confounded by limitations in study design, methodology, and/or heterogeneity in the sample cohort. High-grade serous (HGS) carcinoma is the most clinically important histological subtype of ovarian cancer. As these tumours may arise from the ovary, Fallopian tube ...

2017
Rainer Fagerholm Sofia Khan Marjanka K. Schmidt Montserrat GarcClosas Päivi Heikkilä Jani Saarela Jonathan Beesley Maral Jamshidi Kristiina Aittomäki Jianjun Liu H. Raza Ali Irene L. Andrulis Matthias W. Beckmann Sabine Behrens Fiona M. Blows Hermann Brenner Jenny Chang-Claude Fergus J. Couch Kamila Czene Peter A. Fasching Jonine Figueroa Giuseppe Floris Gord Glendon Qi Guo Per Hall Emily Hallberg Ute Hamann Bernd Holleczek Maartje J. Hooning John L. Hopper Agnes Jager Maria Kabisch kConFab/AOCS Investigators Renske Keeman Veli-Matti Kosma Diether Lambrechts Annika Lindblom Arto Mannermaa Sara Margolin Elena Provenzano Mitul Shah Melissa C. Southey Joe Dennis Michael Lush Kyriaki Michailidou Qin Wang Manjeet K. Bolla Alison M. Dunning Douglas F. Easton Paul D.P . Pharoah Georgia Chenevix-Trench Carl Blomqvist Heli Nevanlinna

TP53 overexpression is indicative of somatic TP53 mutations and associates with aggressive tumors and poor prognosis in breast cancer. We utilized a two-stage SNP association study to detect variants associated with breast cancer survival in a TP53-dependent manner. Initially, a genome-wide study (n = 575 cases) was conducted to discover candidate SNPs for genotyping and validation in the Breas...

2008
Mehdi Nikbahkt Dastjerdi Mansoor Salehi Mohammad Reza Mohajeri Fereshteh Morsali Hamid Mirmohammad Sadeghi Ebrahim Esfandiary

BACKGROUND: A common polymorphism at codon 72 of TP53 gene has been associated with increased risk for many human cancers. We studied this TP53 polymorphism in colorectal adenocarcinomas in small population selected from Isfahan city. METHODS: Samples: We undertook a case-control study on 180 controls and 180 paraffin block specimens of sporadic colorectal adenocarcinomas. PCR amplification of ...

2002
Anita Langerød Ida R. K. Bukholm André Bregård Per Eystein Lønning Tone Ikdal Andersen Torleiv O. Rognum Gunn Iren Meling Ragnhild A. Lothe Anne-Lise Børresen-Dale

An Arg/Pro polymorphism in codon 72 of the TP53 gene was analyzed in blood samples from 390 breast and 162 colorectal cancer patients previously investigated for TP53 mutations in their tumors. Among the breast cancer cases, 228 were homozygous for the Arg72 allele, of which, 65 (28.5%) also had a TP53 mutation in their tumors. In contrast, of 26 cases that were homozygous for the Pro72 allele,...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002
Anita Langerød Ida R K Bukholm André Bregård Per Eystein Lønning Tone Ikdal Andersen Torleiv O Rognum Gunn Iren Meling Ragnhild A Lothe Anne-Lise Børresen-Dale

An Arg/Pro polymorphism in codon 72 of the TP53 gene was analyzed in blood samples from 390 breast and 162 colorectal cancer patients previously investigated for TP53 mutations in their tumors. Among the breast cancer cases, 228 were homozygous for the Arg72 allele, of which, 65 (28.5%) also had a TP53 mutation in their tumors. In contrast, of 26 cases that were homozygous for the Pro72 allele,...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید